Ebola cases top 4,000 in DRC as WHO urges Ervebo vaccine trial

What the report says

Confirmed Ebola cases in the Democratic Republic of the Congo have passed 4,000, according to government figures cited by Al Jazeera, as the country continues to battle a large outbreak of the Bundibugyo strain. The Health Ministry’s latest situation report put the tally at 4,053 cases and 1,850 deaths since the outbreak was declared in mid-May. The article says the outbreak has spread across 53 health zones in five provinces, with most cases in Ituri and a significant share in neighboring North Kivu.

Al Jazeera reported that the World Health Organization’s vaccine experts have recommended a full-scale human trial of Ervebo, the only licensed Ebola vaccine, to assess whether it can help protect against the Bundibugyo strain. WHO experts cited early animal data suggesting some cross-protection, while also noting that a strain-specific Bundibugyo vaccine would still be the preferred tool if available. The Technical Advisory Group on Candidate Vaccine Prioritization cautioned that expectations should be measured.

The outbreak is occurring amid conflict, delayed detection and limited access to treatments and vaccines, factors that can complicate containment. The article also said the epidemic has been described as the fastest-spreading on record, though independent verification of that characterization was not provided in the text. Gavi said stockpiled Ervebo doses could be made available for trials, including some already in the DRC, as health agencies look for ways to reduce severe illness and deaths.